Bioxytran (BIXT) FCF Margin Growth (1y) (2011 - 2018)
Bioxytran (BIXT) FCF Margin Growth (1y) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | 26,102.00 |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 869.00 |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 769.00 |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 4,109.00 |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 19,111.00 |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | 811.00 |
| 10 | Bioxytran | 2.29 Mn | 2.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 863.00 |
| Mar 31, 2018 | 10,755.00 |
| Dec 31, 2017 | 1,354.00 |
| Sep 30, 2017 | 2,514.00 |
| Jun 30, 2017 | 1,249.00 |
| Mar 31, 2017 | -4,778.00 |
| Dec 31, 2016 | -1,383.00 |
| Sep 30, 2016 | -2,334.00 |
| Jun 30, 2016 | -826.00 |
| Mar 31, 2016 | -5,487.00 |
| Dec 31, 2015 | -14,220.00 |
| Sep 30, 2015 | -93.00 |
| Jun 30, 2015 | 10,994.00 |
| Mar 31, 2015 | -2,420.00 |
| Dec 31, 2014 | 13,996.00 |
| Sep 30, 2014 | 28,752.00 |
| Jun 30, 2014 | -10,585.00 |
| Mar 31, 2014 | 1,335.00 |
| Dec 31, 2013 | 1,213.00 |
| Sep 30, 2013 | 34,764.00 |